Allergic rhinitis: Mometasone Furoate suspension is emitted about 100mg in each spray and it contains 0.05mg of Mometasone Furoate (on the anhydrous basis). For uniform spraying. use it after 10 test sprays. If the spray pump has not been used for 14 days or longer, it should be 2 test sprays again before next use
Adults (including geriatric patients) and children 12 years of age and older: The usual recommended dose is 2 sprays in each nostril once daily (total daily dose of 0.2mg). Once symptom are controlled, dose reduction to 1 spray in each nostril (total daily dose of 0.1mg). If symptoms are inadequately controlled, the dose may be increased to a maximum daily dose of 4 sprays in each nostril once daily (total daily dose of 0.4mg). Dose reduction is recommended following control of symptoms. The patient should continue regular use to achieve full therapeutic benefit.
Children 2 to 11 Years of Age: The recommended dose is 1 spray in each nostril once daily (total daily dose of 0.1mg).
Nasal polyps: The usual recommended dose is 2 sprays in each nostril once daily (total daily dose of 0.2mg). If symptoms are inadequately controlled after 5-6 weeks, the dose may be increased to a maximum daily dose of 2 sprays in each nostril twice daily (total daily dose of 0.4mg). Dose reduction is recommended following control of symptoms. If symptoms are still inadequately controlled, other therapy is recommended. There is no evidence that the spray has been used more than 4 months for nasal polyps therapy.
Acute episodes of sinusitis: The recommended dose is 2 sprays in each nostril twice daily (total daily dose of 0.4mg).